Over-Looked and Under-Appreciated Non-MSC Exosomes
Thursday, May 30, 2024 03:45 PM - 04:45 PM
Room 217-219
Concurrent Session
Session has been organised in conjunction with ISEV
Chair
MSC exosomes are currently the most extensively researched and most advanced in clinical development. While exosomes derived from other sources, such as bacteria, milk, and immune cells, receive comparatively less attention in research and clinical applications, they harbor significant clinical potential as vaccines, drug delivery vehicles, or therapeutic agents. Several of these exosomes are either undergoing clinical testing or are on the verge of entering such trials.
Chair
- Sai Kiang Lim, PhD, A*STAR Institute of Molecular Biology, Singapore
- Yong Song Gho, PhD, Pohang University of Science and Technology, ISEV, South Korea, "Bacterial Extracellular Vesicles as Next-Generation Cancer Immunotherapeutic Agents"
- Marca Wauben, PhD, Utrecht University, ISEV, Netherlands, "Milk-derived extracellular vesicles: Properties & potential applications"
- Naohiro Seo, PhD, The University of Tokyo, ISEV, Japan, "The Exosome Population of Cytotoxic T Cell Extracellular Vesicles has an Inhibitory Effect on Tumor Progression"
MSC exosomes are currently the most extensively researched and most advanced in clinical development. While exosomes derived from other sources, such as bacteria, milk, and immune cells, receive comparatively less attention in research and clinical applications, they harbor significant clinical potential as vaccines, drug delivery vehicles, or therapeutic agents. Several of these exosomes are either undergoing clinical testing or are on the verge of entering such trials.
